PhRMA Sees Canadian Currency Devaluation As Grounds For Trade Action
PhRMA believes that the inability of pharmaceutical manufacturers to raise prices in Canada to reflect the devaluation of the Canadian dollar is "contrary to the spirit" of the North American Free Trade Agreement.
You may also be interested in...
Only a small part of recent increases in health insurance premiums can be attributed to the cost of prescription drugs, according to two reports released the week of April 10 by the pharmaceutical and health insurance industries.
Average per capita spending on drugs for Medicare eligibles with drug insurance was 66% higher in 1996 than spending on pharmaceuticals for non-covered elderly, according to an analysis of drug spending released by the Clinton Administration on April 10.
A Maine drug pricing board would use federal supply schedule drug prices and Canadian drug prices to set maximum prescription drug prices in the state under a proposed bill.